Global "Coagulation
Analyzers and Reagents Market" 2024
Industry research report covers the industry overview with Marketplace Size,
Share, Development, futuristic cost, earnings, demand and distribution data. Its
vast repository offers an analytical summary of the marketplace that can help
to the new and existing player to take a significant decision.
In this report, we
thoroughly examine and analyse the Global market for Coagulation Analyzers and
Reagents so that market participants can improve their business strategy and
ensure long-term success. This report provides players with useful information
and suggests result-based ideas to give them a competitive advantage in the
global Coagulation Analyzers and Reagents industry. It will show how other
players compete in the global Coagulation Analyzers and Reagents Market and
explain the strategies you use to differentiate yourself from other
participants.
Download Free Sample
Report Now @ https://www.millioninsights.com/industry-reports/coagulation-analyzers-reagents-market/request-sample
Industry Insights
The global coagulation
analyzers & reagents market size was worth USD 3.3 billion in 2015 and is
likely to grow at a CAGR of over 10.2% over the forecast period. The growth of
this market is supported by increasing number of lifestyle disorders and
chronic blood related disorders.
The increase in the volume
of testing can be attributed to the augmented awareness among people towards
lifestyle and blood disorders which is expected to further improve the
diagnostic rate and preventive care management. The study covers developing
countries which are undergoing paradigm shift and are highly investing
government funds for the procurement and installation of these medical devices
in the public healthcare facilities.
Specifically, for the
developing nations of the Asia Pacific and Middle East region factors such as
increased geriatric population, rapid growth in foreign investments and rising
prevalence of lifestyle disorders are expected to be support market growth.
Another major driving force identified is the increased incidence of haemophilia
as per a report published by the WHO, resulting in the industry growth and
rising installation base and expansion of these medical devices in the
healthcare facilities.
Technological Insights
Over the period of
forecast, optical technology is estimated to hold majority of the shares due to
the increasing combination of photo optical method with immunologics and
chromogenics. This combination has led to the development of multipurpose, high
performance optical hemostasis analyzers.
This segment is further
divided into chromogenic/immunological/photo optical and others. The other
segment includes technologies that are patented by Beckman Coulter Inc.,
Instrumentation Laboratory, Siemens Healthcare and others.
End-use Insights
The major drivers for the
end-use segment of the coagulation analyzer market are rapid expansion in
primary healthcare centers and hospitals, favorable government regulations in
the healthcare facilities combined with availability of advanced equipment with
capacity to perform high accuracy multiple tests.
The major end users of this
market are research institutes, hospitals, diagnostic centers and others. In
2015, diagnostic centers dominated the market due to the high rates of
outsourcing of the diagnostic tests to these centers, but in the forecasted
period hospitals are expected to grow due higher number of installations of
analyzers and consumables on the basis of hospital needs.
Regional Insights
North America held majority
of the revenue shares in 2015 for the global market, which is around 35.0%. The
major drivers for this region are increasing prevalence of disorders belonging
to the cardio metabolic class like Pulmonary Embolism (PE), and Deep Vein
Thrombosis (DVT) and presence of well-established healthcare services.
Regions such as Middle East
and Africa are expected to show higher growth rates due to the growing number
of hospitals, health centers and clinics combined with highly skilled
professionals to provide useful, appropriate and safe healthcare facilities. In
2012 Ministry of Health and Ministry of Public Works announced an investment
worth USD 4.4 billion aimed at expansion and replacement of nine operating
hospitals in the span of next ten years, following which a National Health Plan
was created for the span of 2010-2014 focusing on major expansions in the
healthcare sector.
Competitive Insights
Major players in the market
are namely Siemens Healthcare, Instrumentation Laboratory, and Roche
Diagnostics, Alere, Inc., Thermo Fischer Scientific, and Nihon Kohden. Due to
the easy global accessibility in this market, the major players are already present
in across various countries and are competing to secure the higher market
share.
Distributions of these
products are majorly done by third party vendors presently. For example, Sysmex
entered into an agreement with Dade Behring for the distribution of their
products, which is now a part of Siemens Healthcare Diagnostics. But on the
contrary this trend is expected to change in the forecasted period due to the
increase in the investment to establish offices for distribution within multiple
regions by the players leading to the rise in the momentum of direct supply
agreements in the regions over the period of forecast.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment